Redx Pharma PLC operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Redx Pharma PLC with three other
companies in this sector in UNITED KINGDOM :
Fusion Antibodies PLC
sales of £3.90 million [US$5.35 million]
Silence Therapeutics Plc
(£5.48 million [US$7.53 million]
Reneuron Group PLC
(£6.07 million [US$8.33 million]
of which 100%
was Development of cell-based therapies).